PATIENT GUIDE
Clinical trials carry real risks — but they also have more safety oversight than almost any other medical experience. Understanding both sides helps you make an informed decision.
Informational only. Not medical advice. Always consult a qualified healthcare professional before making decisions about clinical trial participation.
All clinical trials in the US are regulated by the FDA and must follow Good Clinical Practice (GCP) guidelines. Every trial must be approved by an Institutional Review Board (IRB) — an independent ethics committee that reviews the protocol before any patient is enrolled. The IRB monitors the trial throughout its duration.
Most Phase 2 and Phase 3 trials have a Data Safety Monitoring Board (DSMB) — an independent group of experts who review ongoing data to watch for safety signals. If the DSMB identifies unexpected harm, they can recommend pausing or stopping the trial before more patients are affected.
The investigational treatment may have unknown side effects. You may receive a placebo if the trial is randomized. The treatment may not work. Visits may be frequent and time-consuming. Some trials involve procedures with their own risks. These risks are disclosed in the informed consent document — read it carefully.
You can withdraw at any time without affecting your standard care. Side effects must be reported and managed by the study team. You will receive free medical care for any study-related injury. All research on human subjects is governed by the Declaration of Helsinki and the Belmont Report.
Look at the trial phase — Phase 3 carries less uncertainty than Phase 1. Check the sponsor — large pharmaceutical companies and academic medical centers have established safety infrastructure. Ask the study coordinator about the DSMB and how adverse events are handled. Talk to your own physician before enrolling.
COMMON QUESTIONS
What happens if I have a bad reaction during a trial?
You will receive immediate medical treatment at no cost. Serious adverse events must be reported to the IRB, FDA, and sponsor within 24–72 hours. The study may be paused while the reaction is investigated.
Can a trial force me to continue if I want to quit?
No. Participation is always voluntary. You can withdraw at any time for any reason, and your standard medical care will not be affected by your decision to leave.
Are all clinical trial risks disclosed?
All known and reasonably anticipated risks must be disclosed in the informed consent document. Unknown risks — by definition — cannot be disclosed. This is why Phase 1 trials carry more uncertainty than later phases.
Is it safe to participate in a trial while taking other medications?
It depends on the trial. Most trials have exclusion criteria around certain medications that could interfere with results or create dangerous interactions. Always disclose all medications you are taking during the screening process.
Ready to find a trial?
Search thousands of recruiting clinical trials by condition and location.
FIND TRIALS →